JESSICA CARTY: Open Payments
NPI 1174050801 · PARIS, KY. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$299 in 17 payments from 12 companies in 2025. Trend: 2023 $446 · 2024 $623 · 2025 $299
Food & beverage: $299
| Company | Payments | Amount |
|---|---|---|
| Esperion Therapeutics, Inc. | 3 | $54 |
| GlaxoSmithKline, LLC. | 2 | $37 |
| Lilly USA, LLC | 2 | $33 |
| Novo Nordisk Inc | 2 | $32 |
| Verona Pharma, Inc. | 1 | $24 |
| Otsuka America Pharmaceutical, Inc. | 1 | $20 |
| Bayer Healthcare Pharmaceuticals Inc. | 1 | $20 |
| Lundbeck LLC | 1 | $18 |
| Collegium Pharmaceutical, Inc. | 1 | $16 |
| ABBVIE INC. | 1 | $16 |
Products named: NEXLETOL, REXULTI, TRELEGY ELLIPTA, Ohtuvayre, Kerendia, JARDIANCE, Wegovy, Jornay PM.
Industry payments across KY — which companies pay providers there.
